↓ Skip to main content

Dove Medical Press

Cost-effectiveness of an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer in the UK

Overview of attention for article published in Cancer Management and Research, August 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)
  • High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

policy
2 policy sources
twitter
1 X user
googleplus
1 Google+ user

Citations

dimensions_citation
29 Dimensions

Readers on

mendeley
39 Mendeley
Title
Cost-effectiveness of an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer in the UK
Published in
Cancer Management and Research, August 2013
DOI 10.2147/cmar.s44539
Pubmed ID
Authors

Samantha Humphreys, James Pellissier, Alison Jones

Abstract

Prevention of chemotherapy-induced nausea and vomiting (CINV) remains an important goal for patients receiving chemotherapy. The objective of this study was to define, from the UK payer perspective, the cost-effectiveness of an antiemetic regimen using aprepitant, a selective neurokinin-1 receptor antagonist, for patients receiving chemotherapy for breast cancer.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 39 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 3%
Unknown 38 97%

Demographic breakdown

Readers by professional status Count As %
Other 8 21%
Student > Bachelor 7 18%
Researcher 7 18%
Student > Ph. D. Student 4 10%
Student > Master 3 8%
Other 3 8%
Unknown 7 18%
Readers by discipline Count As %
Medicine and Dentistry 15 38%
Pharmacology, Toxicology and Pharmaceutical Science 5 13%
Agricultural and Biological Sciences 4 10%
Chemistry 2 5%
Economics, Econometrics and Finance 1 3%
Other 3 8%
Unknown 9 23%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 November 2023.
All research outputs
#4,811,011
of 25,483,400 outputs
Outputs from Cancer Management and Research
#192
of 2,076 outputs
Outputs of similar age
#38,661
of 210,290 outputs
Outputs of similar age from Cancer Management and Research
#3
of 12 outputs
Altmetric has tracked 25,483,400 research outputs across all sources so far. Compared to these this one has done well and is in the 81st percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,076 research outputs from this source. They receive a mean Attention Score of 3.5. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 210,290 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 12 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.